It has been reported that MHC-II and CIITA are greatly downregulated in CML cases; however, the expression was increased following stimulation by IFNγ, thus proving that the MHC-II pathways remained functional [135]. This evidence concerns the gene CIITA and chronic myelogenous leukemia, BCR-ABL1 positive.